Biotech FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer January 23, 2024
Biotech Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson’s disease January 23, 2024
Biotech Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy January 23, 2024
Biotech Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B January 23, 2024
Biotech Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH January 23, 2024
Biotech PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope January 18, 2024
Search
